URL: http://www.eutos.org/content/e54/e187/index_eng.html
We propose to expand the availability of imatinib monitoring to a European level in order to optimise therapy for a greater number of patients. This will be achieved by providing a Europe-wide monitoring service free of charge (sample transportation and dosing) for a period of 3 years. During this period, a database will be constructed to i) verify the pertinence of the therapeutic threshold by following patients < 1000 ng/ml and ii) to define a toxic concentration. Furthermore, potential dosing laboratories will be selected across Europe (one or two for each of the participating countries) and a dosing service established in the respective countries by collaboration with the Bordeaux centre which will also manage a centralised quality control system.
Created by: D.Goekbuget , generated 2007/12/19 , last changed: 2008/01/08
Printing Date: 11.09.2010 © 2007/2008 ELIC European Leukemia Information Center
